drugset / Trial / NCT01497574

Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes

NCT01497574

Phase 1 Completed 32 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of the pharmacokinetic profiles of insulin detemir and insulin glargine in children and adolescents with type 1 diabetes.

Timeline

Start
2005-05
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic 0.4 iu/kg Subcutaneous
Subject insulin glargine Protein / enzyme biologic 0.4 iu/kg Subcutaneous